Back to search
Resectable Pancreatic Duct Adenocarcinoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Resectable Pancreatic Duct Adenocarcinoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Resectable Pancreatic Duct Adenocarcinoma trials you may qualify forIn patients with resectable pancreatic duct adenocarcinoma (PDAC), curative surgery followed by adjuvant chemotherapy is currently the standard of care. However…
This is a prospective, multi-center, single arm, open label, non-randomized study to evaluate the ability of \[68Ga\]FAPI-46 to detect FAP expressing cells in p…
The aim of our study is to build up biological, radiological and tissue collections so as to identify, at the time of diagnosis of pancreatic adenocarcinoma, mu…